Multiple Myeloma Associate Scientific Director

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

The Multiple Myeloma Associate Scientific Director, is responsible for medical and scientific leadership within the assigned therapeutic area to ensure seamless integration of inline and pipeline assets into the health care system. As a remote, head-office role, the Associate Scientific Director will lead Key Institution Management by implementing institution plans for key sites and networks within geographic regions, focusing on scientific, clinical, and evidence-generation activities. This role drives Medical Affairs strategy at assigned Canada institutions focusing on innovation and across portfolio-wide Hematology-Oncology activities. The Associate Scientific Director is responsible and accountable for providing high level, evidenced-based, scientific expertise to internal and external partners and stakeholders. This role plays a key strategic role in developing and advancing the scientific objectives of the organization. In collaboration with Field Managers, the Associate Scientific Director provides direction and guidance to the MSL Team on areas of interest to Janssen to develop and implement field-based activities aligned with the Medical Affairs Plan and Strategy.

Responsibilities include but are not limited to:

Lead the development of strategy for key institution management and implement institution plans for key sites and networks within assigned geographic regions that support the Hematology-Oncology pipeline of products

Establish and maintain trusted peer-to-peer relationships with KOLs to collaborate on scientific projects, share balanced scientific data, collect insights and collaborate on future clinical research/publications

Drive pre-launch and launch activities and strategic projects from Launch Readiness (LRT), Medical integration (MIT) and Patient Value Teams (PVT), as relevant to key institutions

Lead and coordinate field engagement with key institutions focusing on medical and research initiatives, as well as strategic projects and partnerships

Develop and maintain relationships with external opinion leaders/investigators involved in the delivery of care in Hematology-Oncology or engaged in related studies

Provide strategic input/direction to therapeutic MSLs/MSL Manager in the development and execution of their functions

Provide strategic scientific support to key stakeholders (marketing, access, regulatory) with respect to pipeline products

Identify internal scientific training needs and collaborate with functional partners in its development and execution to ensure organizational readiness

Collaborate with Medical Director and/or Therapeutic Area Head to build the pre-launch medical strategy, participate and co-lead NBD IEGP (As required) for all qualifying pipeline products

In collaboration with the Therapeutic Area Head, identify and develop future clinical trial investigators and new trial sites to ensure quick adoption of new disease areas and technologies

A minimum of a Doctoral degree is required; PhD, PharmD or MD

Minimum of 5 years relevant therapeutic and/or pharmaceutical experience, strong clinical and/or scientific background and track record of collaboration in a matrix environment

Prior Hematology/Oncology experience is highly preferred

Excellent written and verbal communication skills with both scientific and lay audiences

Proven track record developing, presenting and publishing clinical or related evidence generation studies

Strong leadership skills and the ability to motivate teams

Strong planning and organizational skills: manage multiple projects concurrently

Demonstration of a strong publication track record

Ability to work effectively in a matrix project team environment, partnered with strong project management and execution skills (proactive in identifying opportunities)

Ability to critically review the medical literature and summarize the results for internal partners

Expert in navigating clinical or medical project approval systems, in statistical methods and processes for successful publication

Ability to (international & domestic) travel as required approximately 40%

Johnson & Johnson is an Affirmative Action and Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, or protected veteran status and will not be discriminated against on the basis of disability.

ERADICATE CANCER